L92 (3A1) - Mild and Moderate Hepatic Impairment Patients
Gender: Male and Female
Smoking habit: Smoker or non-smoker
Pot smoking
18 - 75
BMI : 18.00 - 42.00
Food restrictions : Fast
Clinic stay
- 27 Aug (17:30) to 1 Sep (09:00)
Participants must be available to stay at our clinic for all of the dates listed above and/or in the notes below. All clinic stays and return visits are mandatory. Times are subject to change.
Medication type
For the treatment of multiple sclerosis.
Notes
We are looking for participants with a mild and moderate hepatic impairment.
Phase 1 study.
Eight hours fasting before medical exam.
You will receive $200 after completing the medical exam.
Participants must be fasted prior to each dosing.
Participants will remain seated for at least one hour after taking the medication.
Catheter: yes.
Blood volume: male 122ml / female 122ml (17 blood draws).
A follow-up telephone call will be made to all participants approximately one week following the last drug administration.
Your medical history and/or medication intake history may affect your participation on this study.
Please note that we are testing for drugs and alcohol during the medical evaluation.
This is preliminary information and changes could occur without notice